{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:34:32Z","timestamp":1767713672366,"version":"build-2065373602"},"reference-count":68,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Background: There is a broad range of potential differential diagnoses for chorea. Besides rare, inherited neurodegenerative diseases such as Huntington\u2019s disease (HD) chorea can accompany basal ganglia disorders due to vasculitis or infections, e.g., with the human immunodeficiency virus (HIV). The clinical picture is complicated by the rare occurrence of HIV infection and HD. Methods: First, we present a case suffering simultaneously from HIV and HD (HIV\/HD) focusing on clinical manifestation and disease onset. We investigated cross-sectional data regarding molecular genetic, motoric, cognitive, functional, and psychiatric disease manifestation of HIV\/HD in comparison to motor-manifest HD patients without HIV infection (nonHIV\/HD) in the largest cohort of HD patients worldwide using the registry study ENROLL-HD. Data were analyzed using ANCOVA analyses controlling for covariates of age and CAG repeat length between groups in IBM SPSS Statistics V.25. Results: The HD diagnosis in our case report was delayed by approximately nine years due to the false assumption that the HIV infection might have been the cause of chorea. Out of n = 21,116 participants in ENROLL-HD, we identified n = 10,125 motor-manifest HD patients. n = 23 male participants were classified as suffering from HIV infection as a comorbidity, compared to n = 4898 male non-HIV\/HD patients. Except for age, with HIV\/HD being significantly younger (p &lt; 0.050), we observed no group differences regarding sociodemographic, genetic, educational, motoric, functional, and cognitive parameters. Male HIV\/HD patients reported about a 5.3-year-earlier onset of HD symptoms noticed by themselves compared to non-HIV\/HD (p &lt; 0.050). Moreover, patients in the HIV\/HD group had a longer diagnostic delay of 1.8 years between onset of symptoms and HD diagnosis and a longer time regarding assessment of first symptoms by the rater and judgement of the patient (all p &lt; 0.050). Unexpectedly, HIV\/HD patients showed less irritability in the Hospital Anxiety and Depression Scale (all p &lt; 0.05). Conclusions: The HD diagnosis in HIV-infected male patients is secured with a diagnostic delay between first symptoms noticed by the patient and final diagnosis. Treating physicians therefore should be sensitized to think of potential alternative diagnoses in HIV-infected patients also afflicted by movement disorders, especially if there is evidence of subcortical atrophy and a history of hyperkinesia, even without a clear HD-family history. Those patients should be transferred for early genetic testing to avoid further unnecessary diagnostics and improve sociomedical care.<\/jats:p>","DOI":"10.3390\/brainsci11060710","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T11:07:02Z","timestamp":1622113622000},"page":"710","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Differential Diagnosis of Chorea\u2014HIV Infection Delays Diagnosis of Huntington\u2019s Disease by Years"],"prefix":"10.3390","volume":"11","author":[{"given":"Jannis","family":"Achenbach","sequence":"first","affiliation":[{"name":"Department of Neurology, Huntington Center North Rhine-Westphalia, Ruhr-University Bochum, St. Josef-Hospital Bochum, Gudrunstra\u00dfe 56, 44791 Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Faissner","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huntington Center North Rhine-Westphalia, Ruhr-University Bochum, St. Josef-Hospital Bochum, Gudrunstra\u00dfe 56, 44791 Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Saft","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huntington Center North Rhine-Westphalia, Ruhr-University Bochum, St. Josef-Hospital Bochum, Gudrunstra\u00dfe 56, 44791 Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"ref_2","first-page":"905","article-title":"The function of Huntington disease gene product (huntingtin) and the pathomechanism of Huntington disease","volume":"57","author":"Nukina","year":"1999","journal-title":"Nihon Rinsho"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Van Well, E.M., Bader, V., Patra, M., S\u00e1nchez-Vicente, A., Meschede, J., Furthmann, N., Schnack, C., Blusch, A., Longworth, J., and Petrasch-Parwez, E. (2019). A protein quality control pathway regulated by linear ubiquitination. EMBO J., 38.","DOI":"10.15252\/embj.2018100730"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00702-004-0201-4","article-title":"Huntington\u2019s disease: Pathomechanism and therapeutic perspectives","volume":"111","year":"2004","journal-title":"J. Neural Transm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/011542650802300135","article-title":"Neurodegeneration and inflammation","volume":"23","author":"DeLegge","year":"2008","journal-title":"Nutr. Clin. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/jnc.14674","article-title":"Inflammatory mechanisms in neurodegeneration","volume":"149","author":"Nichols","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12974-019-1564-7","article-title":"The endotoxin hypothesis of neurodegeneration","volume":"16","author":"Brown","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fimmu.2019.00362","article-title":"Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System","volume":"10","author":"Carpanini","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington\u2019s disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1326-9-49","article-title":"Increase of angiotensin II type 1 receptor auto-antibodies in Huntington\u2019s disease","volume":"9","author":"Lee","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1038\/s41598-017-04990-1","article-title":"Laquinimod treatment in the R6\/2 mouse model","volume":"7","author":"Ellrichmann","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ellrichmann, G., Petrasch-Parwez, E., Lee, D.-H., Reick, C., Arning, L., Saft, C., Gold, R., and Linker, R.A. (2011). Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington\u2019s disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016172"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.expneurol.2016.08.012","article-title":"Expression of brain-derived neurotrophic factor in astrocytes\u2014Beneficial effects of glatiramer acetate in the R6\/2 and YAC128 mouse models of Huntington\u2019s disease","volume":"285","author":"Reick","year":"2016","journal-title":"Exp. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","article-title":"FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease","volume":"23","author":"Amico","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S16.007","DOI":"10.1212\/WNL.92.15_supplement.S16.007","article-title":"The Efficacy and Safety Results of Laquinimod as a Treatment for Huntington Disease (LEGATO-HD) (S16.007)","volume":"92","author":"Reilmann","year":"2019","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2174\/1871527315666160321104749","article-title":"Disease-Induced Neuroinflammation and Depression","volume":"15","author":"Benatti","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Toldi, J., and V\u00e9csei, L. (2020). Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072431"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1212\/NXI.0000000000000551","article-title":"Antineuroinflammatory drugs in HIV-associated neurocognitive disorders as potential therapy","volume":"6","author":"Ambrosius","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Scimone, C., Alibrandi, S., Scalinci, S.Z., Trovato Battagliola, E., D\u2019Angelo, R., Sidoti, A., and Donato, L. (2020). Expression of Pro-Angiogenic Markers Is Enhanced by Blue Light in Human RPE Cells. Antioxidants, 9.","DOI":"10.3390\/antiox9111154"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Donato, L., Scimone, C., Alibrandi, S., Abdalla, E.M., Nabil, K.M., D\u2019Angelo, R., and Sidoti, A. (2020). New Omics-Derived Perspectives on Retinal Dystrophies: Could Ion Channels-Encoding or Related Genes Act as Modifier of Pathological Phenotype?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010070"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2174\/1871527313666140806125841","article-title":"Is human immunodeficiency virus-mediated dementia an autophagic defect that leads to neurodegeneration?","volume":"13","author":"Passeri","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11481-012-9353-4","article-title":"When human immunodeficiency virus meets chemokines and microglia: Neuroprotection or neurodegeneration?","volume":"8","author":"Mocchetti","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ceccarelli, G., Brenchley, J.M., Cavallari, E.N., Scheri, G.C., Fratino, M., Pinacchio, C., Schietroma, I., Fard, S.N., Scagnolari, C., and Mezzaroma, I. (2017). Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals. Nutrients, 9.","DOI":"10.3390\/nu9111269"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/jcpt.13315","article-title":"Antiretroviral treatment leading to secondary trimethylaminuria: Genetic associations and successful management with riboflavin","volume":"46","author":"Scimone","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-63849-6.00002-5","article-title":"HIV neuropathology","volume":"152","author":"Morgello","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.expneurol.2014.08.011","article-title":"Cytoplasmic HIV-RNA in monocytes determines microglial activation and neuronal cell death in HIV-associated neurodegeneration","volume":"261","author":"Faissner","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-017-0829-2","article-title":"Teriflunomide and monomethylfumarate target HIV-induced neuroinflammation and neurotoxicity","volume":"14","author":"Ambrosius","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/B978-0-444-52014-2.00025-2","article-title":"Hyperkinetic movement disorders associated with HIV and other viral infections","volume":"100","author":"Carroll","year":"2011","journal-title":"Handb. Clin. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/00023210-200216100-00002","article-title":"HIV-related movement disorders: Epidemiology, pathogenesis and management","volume":"16","author":"Cardoso","year":"2002","journal-title":"CNS Drugs"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2055-6640(20)30007-8","article-title":"Chorea associated with persistent low-level viremia in a patient living with HIV: A case report","volume":"6","author":"Rajakaruna","year":"2020","journal-title":"J. Virus Erad."},{"key":"ref_32","first-page":"279","article-title":"Coreoatetosis como manifestaci\u00f3n inicial de VIH-SIDA","volume":"24","year":"2009","journal-title":"Neurologia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0956462414564608","article-title":"Hemichorea in a patient with HIV-associated central nervous system histoplasmosis","volume":"27","year":"2016","journal-title":"Int. J. STD AIDS"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3233\/JHD-180287","article-title":"Human Immunodeficiency Virus Infection in Huntington\u2019s Disease is Associated with an Earlier Age of Symptom Onset","volume":"7","author":"Schultz","year":"2018","journal-title":"J. Huntingtons. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Achenbach, J., Saft, C., and Faissner, S. (2021). Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington\u2019s Disease\u2014Data from a Real World Cohort. Brain Sci., 11.","DOI":"10.3390\/brainsci11040413"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0733-8619(05)70368-6","article-title":"Complications of Lumbar Puncture","volume":"16","author":"Evans","year":"1998","journal-title":"Neurol. Clin."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.drudis.2014.03.005","article-title":"Genetics of Huntington\u2019s disease and related disorders","volume":"19","author":"Burgunder","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-801893-4.00010-9","article-title":"Genetic testing for Huntington disease","volume":"144","author":"Quaid","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/practneurol-2013-000790","article-title":"Diagnostic genetic testing for Huntington\u2019s disease","volume":"15","author":"Craufurd","year":"2015","journal-title":"Pract. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/mds.25422","article-title":"Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington\u2019s disease","volume":"28","author":"Hart","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e01704","DOI":"10.1002\/brb3.1704","article-title":"Functional and cognitive capacity differ in dystonic motor subtypes when compared to choreatic and hypokinetic-rigid motor subtypes in Huntington\u2019s disease","volume":"10","author":"Achenbach","year":"2020","journal-title":"Brain Behav."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Saft, C., Lauter, T., Kraus, P.H., Przuntek, H., and Andrich, J.E. (2006). Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington\u2019s Disease patients: A case series. BMC Neurol., 6.","DOI":"10.1186\/1471-2377-6-11"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-801893-4.00001-8","article-title":"Genetics of Huntington disease","volume":"144","author":"Nance","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JHD-170256","article-title":"The Impact of Family History on the Clinical Features of Huntington\u2019s Disease","volume":"6","author":"Kringlen","year":"2017","journal-title":"J. Huntingtons. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-444-63233-3.00009-9","article-title":"Repeat expansion diseases","volume":"147","author":"Paulson","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(16)30350-7","article-title":"DNA repair in the trinucleotide repeat disorders","volume":"16","author":"Jones","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/jmg.25.9.589","article-title":"Anticipation in Huntington\u2019s disease is inherited through the male line but may originate in the female","volume":"25","author":"Ridley","year":"1988","journal-title":"J. Med. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: A clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1590\/S0004-27492008000500020","article-title":"Vitreitis and movement disorder associated with neurosyphilis and human immunodeficiency virus (HIV) infection: Case report","volume":"71","author":"Pereira","year":"2008","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Achenbach, J., Thiels, C., L\u00fccke, T., and Saft, C. (2020). Clinical Manifestation of Juvenile and Pediatric HD Patients: A Retrospective Case Series. Brain Sci., 10.","DOI":"10.3390\/brainsci10060340"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.idc.2019.04.006","article-title":"HIV and Substance Use Disorder: Role of the HIV Physician","volume":"33","author":"Bositis","year":"2019","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/S2352-3018(19)30343-1","article-title":"Stigma reduction interventions in people living with HIV to improve health-related quality of life","volume":"7","author":"Andersson","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1089\/apc.2018.0114","article-title":"HIV-Related Stigma by Healthcare Providers in the United States: A Systematic Review","volume":"32","author":"Geter","year":"2018","journal-title":"AIDS Patient Care STDS"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1037\/rep0000311","article-title":"Understanding domains that influence perceived stigma in individuals with Huntington disease","volume":"65","author":"Boileau","year":"2020","journal-title":"Rehabil. Psychol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Portilla-Tamarit, J., Reus, S., Portilla, I., Fuster Ruiz-de-Apodaca, M.J., and Portilla, J. (2021). Impact of Advanced HIV Disease on Quality of Life and Mortality in the Era of Combined Antiretroviral Treatment. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040716"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","article-title":"HIV-1-associated neurocognitive disorder: Epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J. Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.ne.19.030196.000245","article-title":"Human immunodeficiency virus and the brain","volume":"19","author":"Glass","year":"1996","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ncl.2018.07.002","article-title":"Human Immunodeficiency Virus and the Nervous System","volume":"36","author":"Sutherland","year":"2018","journal-title":"Neurol. Clin."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.2009.05277.x","article-title":"Human immunodeficiency virus-associated neurocognitive disorder: Pathophysiology in relation to drug addiction","volume":"1187","author":"Nath","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1086\/344528","article-title":"Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia","volume":"186","author":"Nath","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2008-1040830","article-title":"Pathobiology of human immunodeficiency virus dementia","volume":"19","author":"Nath","year":"1999","journal-title":"Semin. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/glia.10155","article-title":"Microglia in human immunodeficiency virus-associated neurodegeneration","volume":"40","author":"Garden","year":"2002","journal-title":"Glia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","article-title":"Population-based norms for the Mini-Mental State Examination by age and educational level","volume":"269","author":"Crum","year":"1993","journal-title":"JAMA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1586\/14787210.2014.910112","article-title":"A cure for HIV: Is it in sight?","volume":"12","author":"Pace","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","article-title":"HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment","volume":"368","author":"Simon","year":"2006","journal-title":"Lancet"},{"key":"ref_66","first-page":"137","article-title":"Central Nervous System Complications in HIV Disease: HIV-Associated Neurocognitive Disorder","volume":"19","author":"Letendre","year":"2016","journal-title":"Top. Antivir. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1086\/650743","article-title":"Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study","volume":"50","author":"Winston","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"19655","DOI":"10.7448\/IAS.17.4.19655","article-title":"Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals","volume":"17","author":"Libertone","year":"2014","journal-title":"J. Int. AIDS Soc."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/11\/6\/710\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:08:47Z","timestamp":1760162927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/11\/6\/710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":68,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["brainsci11060710"],"URL":"https:\/\/doi.org\/10.3390\/brainsci11060710","relation":{},"ISSN":["2076-3425"],"issn-type":[{"type":"electronic","value":"2076-3425"}],"subject":[],"published":{"date-parts":[[2021,5,27]]}}}